BFRIW
Biofrontera Inc.
Biofrontera Inc. (BFRIW) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 48.0, with 0/3 trend checks passing.
BFRIW with MA50 and MA200
Key levels & signals
Biofrontera Inc. (BFRIW) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.03, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 21.1% and below the 200-day moving average by 60.3%.
BFRIW currently has an RSI reading of 48.0, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.
For traders reviewing BFRIW next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About Biofrontera Inc.
Biofrontera Inc. is a biopharmaceutical firm specializing in the commercialization of pharmaceutical solutions for skin-related ailments across the United States. Its product lineup features Ameluz, a prescription drug employed with the BF-RhodoLED lamp series for photodynamic therapy. This treatment is designed for both localized and broader area management of mild-to-moderate actinic keratosis on the face and scalp. Additionally, the company offers Xepi, a topical, non-fluorinated quinolone that functions by inhibiting bacterial growth to treat impetigo. Established in 2015, Biofrontera Inc. is headquartered in Woburn, Massachusetts.
Learn the indicators behind this page
More stock opportunities
Common questions about BFRIW
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.